Loss of miR-204 expression is a key event in melanoma

Galasso, Marco; Morrison, Carl; Minotti, Linda; Corrà, Fabio; Zerbinati, Carlotta; Agnoletto, Chiara; Baldassari, Federica; Fassan, Matteo; Bartolazzi, Armando; Vecchione, Andrea; Nuovo, Gerard J.; Di Leva, Gianpiero; D’Atri, Stefania; Alvino, Ester; Previati, Maurizio; Nickoloff, Brian J.; Croce, Carlo M.; Volinia, Stefano

doi:10.1186/s12943-018-0819-8

All Outputs (3)

Abstract 1850: CDK inhibitor PHA-848125 preferentially inhibits proliferation of triple negative breast cancer and synergizes with cisplatin (2018)
Journal Article
Cheung, D. G., Buzzetti, M., Croce, C. M., & Leva, G. D. (2018). Abstract 1850: CDK inhibitor PHA-848125 preferentially inhibits proliferation of triple negative breast cancer and synergizes with cisplatin. Cancer Research, 78(13_Supplement), 1850-1850. https://doi.org/10.1158/1538-7445.am2018-1850

Circulating Micrornas Predict Survival of Patients with Tumors of Glial Origin (2018)
Journal Article
Di Leva. (2018). Circulating Micrornas Predict Survival of Patients with Tumors of Glial Origin. EBioMedicine, 105 -112. https://doi.org/10.1016/j.ebiom.2018.03.022

The World Health Organization has recently introduced molecular prognostic-diagnostic biomarkers in the classification of Central Nervous System (CNS) tumors. In order to characterize subclasses of tumors that cannot find a precise location in the cu... Read More about Circulating Micrornas Predict Survival of Patients with Tumors of Glial Origin.

Loss of miR-204 expression is a key event in melanoma (2018)
Journal Article
Galasso, M., Morrison, C., Minotti, L., Corrà, F., Zerbinati, C., Agnoletto, C., …Volinia, S. (2018). Loss of miR-204 expression is a key event in melanoma. Molecular cancer, 17, Article 71. https://doi.org/10.1186/s12943-018-0819-8

Cutaneous melanoma (CM) is a malignancy with increasing occurrence. Its microRNA repertoire has been defined in a number studies, leading to candidates for biological and clinical relevance: miR-200a/b/c, miR-203, miR-205, miR-204, miR-211, miR-23b a... Read More about Loss of miR-204 expression is a key event in melanoma.